Cargando…
Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1
The aim of this study was to investigate whether calcium dobesilate (calcium dihydroxy-2,5-benzenesulfonate) may be used to treat diabetic nephropathy. A total of 121 patients with type 2 diabetic nephropathy received calcium dobesilate (500 mg, 3 times a day) for 3 months. The levels of glycated he...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524077/ https://www.ncbi.nlm.nih.gov/pubmed/23251286 http://dx.doi.org/10.3892/etm.2012.755 |